These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 417615

  • 1. Treatment of obesity: cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs.
    Dahms WT, Molitch ME, Bray GA, Greenway FL, Atkinson RL, Hamilton K.
    Am J Clin Nutr; 1978 May; 31(5):774-8. PubMed ID: 417615
    [Abstract] [Full Text] [Related]

  • 2. Three controlled trials of weight loss with phenylpropanolamine.
    Altschuler S, Conte A, Sebok M, Marlin RL, Winick C.
    Int J Obes; 1982 May; 6(6):549-56. PubMed ID: 6761288
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of behavioral techniques reinforced with an anorectic drug in a double-blind weight loss study.
    Abramson R, Garg M, Cioffari A, Rotman PA.
    J Clin Psychiatry; 1980 Jul; 41(7):234-7. PubMed ID: 6993445
    [Abstract] [Full Text] [Related]

  • 4. A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.
    Murphy JE, Donald JF, Molla AL, Crowder D.
    J Int Med Res; 1975 Jul; 3(3):202-6. PubMed ID: 162676
    [Abstract] [Full Text] [Related]

  • 5. Diethylpropion and mazindol: An end to the discussion?
    Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, Correr CJ.
    Rev Assoc Med Bras (1992); 2017 Mar; 63(3):203-206. PubMed ID: 28489121
    [Abstract] [Full Text] [Related]

  • 6. Treatment of obesity. Appetite suppressant drugs and intestinal by-pass surgery.
    Bleehen SS, Edwards IR, Clark RG.
    Br J Dermatol; 1976 Aug; 95(2):219-222. PubMed ID: 782507
    [No Abstract] [Full Text] [Related]

  • 7. Use of an anorexic drug in a total weight reduction program in private practice.
    Nolan GR.
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):332-7. PubMed ID: 809245
    [No Abstract] [Full Text] [Related]

  • 8. Obesity.
    Arterburn D, DeLaet D, Flum D.
    Clin Evid; 2005 Jun; (13):707-25. PubMed ID: 16135277
    [No Abstract] [Full Text] [Related]

  • 9. Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.
    Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, Correr CJ.
    Clinics (Sao Paulo); 2017 May; 72(5):317-324. PubMed ID: 28591345
    [Abstract] [Full Text] [Related]

  • 10. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
    Cercato C, Roizenblatt VA, Leança CC, Segal A, Lopes Filho AP, Mancini MC, Halpern A.
    Int J Obes (Lond); 2009 Aug; 33(8):857-65. PubMed ID: 19564877
    [Abstract] [Full Text] [Related]

  • 11. A double blind controlled trial of a new anorectic agent AN448.
    Woodhouse SP, Nye ER, Anderson K, Rawlings J.
    N Z Med J; 1975 Jun 25; 81(542):546-9. PubMed ID: 1099491
    [Abstract] [Full Text] [Related]

  • 12. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A, Larsen S, Hey H, Stokholm KH, Juhl E, Quaade F.
    Int J Obes; 1981 Jun 25; 5(2):183-7. PubMed ID: 7228474
    [Abstract] [Full Text] [Related]

  • 13. [Adjuvant anorectic therapy--value and tolerance].
    Maibach E.
    Med Welt; 1978 Aug 11; 29(32):1249-53. PubMed ID: 672595
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial.
    Atkinson RL, Greenway FL, Bray GA, Dahms WT, Molitch ME, Hamilton K, Rodin J.
    Int J Obes; 1977 Aug 11; 1(2):113-20. PubMed ID: 363629
    [Abstract] [Full Text] [Related]

  • 15. The current status of antiobesity drugs.
    Galloway SM, Farquhar DL, Munro JF.
    Postgrad Med J; 1984 Aug 11; 60 Suppl 3():19-26. PubMed ID: 6393107
    [Abstract] [Full Text] [Related]

  • 16. Diethylpropion hydrochloride: an effective appetite suppressant.
    Bolding OT.
    Curr Ther Res Clin Exp; 1974 Jan 11; 16(1):40-8. PubMed ID: 4203847
    [No Abstract] [Full Text] [Related]

  • 17. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
    Dolecek R.
    Cas Lek Cesk; 1975 Feb 21; 114(8):249-54. PubMed ID: 1095197
    [No Abstract] [Full Text] [Related]

  • 18. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec 20; 12(26):101-2. PubMed ID: 4459058
    [No Abstract] [Full Text] [Related]

  • 19. Obesity.
    Arterburn D.
    Clin Evid; 2003 Dec 20; (10):676-89. PubMed ID: 15555115
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.